Empire Genomics

Empire Genomics is a leading provider of FISH probe technology, serving the clinical diagnostics and research markets with a broad catalog of standardized and custom probes. The company's core strength lies in its extensive BAC clone library and its ability to deliver custom probe designs within two weeks, supported by stringent quality control. It has successfully expanded its portfolio to include automation-compatible probes and ancillary reagents, positioning itself as an integrated solutions provider in the cytogenetics and molecular pathology space. With a commercial business model, Empire Genomics generates revenue through product sales and services, supplying major cancer centers globally.

Proprietary BAC (Bacterial Artificial Chromosome) library from the Human Genome Project for FISH probe design and manufacturing, supported by BAC End Sequencing for quality control. Platform supports manual and automated FISH assays for FFPE, cytology, and hematology samples.

Empire Genomics competes in the specialized FISH probe market against large diagnostic companies like Abbott Molecular, Agilent, and Cytocell (Oxford Gene Technology), as well as other niche players. Its differentiation lies in its rapid custom probe design, extensive BAC library, and focus on automation compatibility and customer support.